CSIMarket
 


Bio rad Laboratories Inc   (BIO)
Other Ticker:  
 

Bio Rad Laboratories Inc 's Leverage Ratio

BIO's quarterly Leverage Ratio and Total Liabilities, Equity growth


Despite a net increase in borrowings by 2.24%, Bio Rad Laboratories Inc managed to enhance Leverage Ratio in the forth quarter 2023 to 0.4, falling below the company's typical Leverage Ratio.

Within Laboratory Analytical Instruments industry Bio rad Laboratories Inc achieved the lowest Leverage Ratio in the forth quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the third quarter 2023 from 57 to 147 .

Explain Leverage Ratio?
Who are BIO Customers?
What are BIO´s Total Liabilities?


BIO Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -9.09 % -0.44 % -5.33 % -4.12 % -29.65 %
Y / Y Total Liabilities Change -9.49 % -3.65 % -6.15 % -6.9 % -4.56 %
Leverage Ratio MRQ 0.4 0.41 0.41 0.4 0.4
BIO's Total Ranking # 147 # 57 # 629 # 710 # 160
Seq. Equity Change 3.86 % -0.36 % -13.49 % 1.54 % 13.74 %
Seq. Total Liabilities Change 2.24 % -1.55 % -9.64 % -0.49 % 8.84 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 40
Overall Market # 147


Leverage Ratio Statistics
High Average Low
0.78 0.47 0.3
(Dec 31 2011)   (Dec 31 2021)




Financial Statements
Bio Rad Laboratories Inc 's Equity $ 8,741 Millions Visit BIO's Balance sheet
Bio Rad Laboratories Inc 's Total Liabilities $ 3,518 Millions Visit BIO's Balance sheet
Source of BIO's Sales Visit BIO's Sales by Geography


Cumulative Bio Rad Laboratories Inc 's Leverage Ratio

BIO's Leverage Ratio for the trailling 12 Months

BIO Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -9.09 % -0.44 % -5.33 % -4.12 % -29.65 %
Y / Y Total Liabilities TTM Growth -9.49 % -3.65 % -6.15 % -6.9 % -4.56 %
Leverage Ratio TTM 0.4 0.41 0.41 0.41 0.41
Total Ranking TTM # 1 # 808 # 35 # 5 # 923
Seq. Equity TTM Growth 3.86 % -0.36 % -13.49 % 1.54 % 13.74 %
Seq. Total Liabilities TTM Growth 2.24 % -1.55 % -9.64 % -0.49 % 8.84 %


On the trailing twelve months basis Despite of the net new borrowings of 2.24% during the twelve months period ending in IV Quarter 2023 Bio Rad Laboratories Inc has managed to decrease Leverage Ratio in the IV Quarter 2023 to 0.4, below Bio Rad Laboratories Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Laboratory Analytical Instruments industry BIO recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 1, from total ranking in previous 12 month period at 808.

Explain Leverage Ratio?
Who are BIO Customers?
What are BIO´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 1
Within the Market # 1


trailing twelve months Leverage Ratio Statistics
High Average Low
0.62 0.43 0.3
(Dec. 30, 2013)   (Dec 31 2021)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Laboratory Analytical Instruments Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Harvard Bioscience Inc  0.88 $ 64.292  Millions$ 73.074  Millions
Illumina Inc   0.53 $ 3,059.000  Millions$ 5,745.000  Millions
Bio rad Laboratories Inc   0.40 $ 3,517.558  Millions$ 8,741.133  Millions
Cue Health Inc   0.36 $ 89.535  Millions$ 250.252  Millions
Cytek Biosciences Inc   0.23 $ 91.914  Millions$ 393.064  Millions
Quanterix Corp  0.23 $ 78.084  Millions$ 346.927  Millions
Nautilus Biotechnology Inc   0.15 $ 40.212  Millions$ 265.353  Millions

Date modified: 2024-02-17T14:02:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com